[
  {
    "ts": null,
    "headline": "Dividend Watch: 3 Companies Boosting Payouts",
    "summary": "Everybody loves dividends, as they provide a passive income stream, limit drawdowns in other positions, and provide more than one way to profit from an investment.",
    "url": "https://finnhub.io/api/news?id=5897b86e47903660c54ef851930859b87c0b7f58a6ef72e2ffef5977118ea963",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754606640,
      "headline": "Dividend Watch: 3 Companies Boosting Payouts",
      "id": 136267145,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MCK",
      "source": "Yahoo",
      "summary": "Everybody loves dividends, as they provide a passive income stream, limit drawdowns in other positions, and provide more than one way to profit from an investment.",
      "url": "https://finnhub.io/api/news?id=5897b86e47903660c54ef851930859b87c0b7f58a6ef72e2ffef5977118ea963"
    }
  },
  {
    "ts": null,
    "headline": "Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2025",
    "summary": "$60.0M in 2Q25 Total Product Revenue More than 100 Patients Treated with Amtagvi® in 2Q25 Strategic Restructuring Extends Cash Runway into 4Q26 FY25 Total Product Revenue Guidance of $250M-$300M Reiterated SAN CARLOS, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today reported secon",
    "url": "https://finnhub.io/api/news?id=1a4e2d23390f352bb29f14ecaf0fe0a1bfcf3a62a8a1e1e001f53cc0d9e16141",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754596860,
      "headline": "Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2025",
      "id": 136267146,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MCK",
      "source": "Yahoo",
      "summary": "$60.0M in 2Q25 Total Product Revenue More than 100 Patients Treated with Amtagvi® in 2Q25 Strategic Restructuring Extends Cash Runway into 4Q26 FY25 Total Product Revenue Guidance of $250M-$300M Reiterated SAN CARLOS, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today reported secon",
      "url": "https://finnhub.io/api/news?id=1a4e2d23390f352bb29f14ecaf0fe0a1bfcf3a62a8a1e1e001f53cc0d9e16141"
    }
  },
  {
    "ts": null,
    "headline": "Precipio: Cash Flow Positivity May Remove Going Concern Language",
    "summary": "Deep Sail Capital highlights Precipioâs path to cash flow positivity and niche growth in cancer diagnostics. See why its turnaround story deserves a closer look.",
    "url": "https://finnhub.io/api/news?id=c384ce4b6028ab55765fe4386e474bfc60535242c93ca10f772e172fe22d64de",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754595900,
      "headline": "Precipio: Cash Flow Positivity May Remove Going Concern Language",
      "id": 136263091,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1295493003/image_1295493003.jpg?io=getty-c-w1536",
      "related": "MCK",
      "source": "SeekingAlpha",
      "summary": "Deep Sail Capital highlights Precipioâs path to cash flow positivity and niche growth in cancer diagnostics. See why its turnaround story deserves a closer look.",
      "url": "https://finnhub.io/api/news?id=c384ce4b6028ab55765fe4386e474bfc60535242c93ca10f772e172fe22d64de"
    }
  },
  {
    "ts": null,
    "headline": "McKesson Corp. stock underperforms Thursday when compared to competitors",
    "summary": "McKesson Corp. stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=d0980929f6ff87f97cf0c0665f5c9f72ce81444cfc5b909a266ac790f47dda05",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754584200,
      "headline": "McKesson Corp. stock underperforms Thursday when compared to competitors",
      "id": 136300204,
      "image": "",
      "related": "MCK",
      "source": "MarketWatch",
      "summary": "McKesson Corp. stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=d0980929f6ff87f97cf0c0665f5c9f72ce81444cfc5b909a266ac790f47dda05"
    }
  },
  {
    "ts": null,
    "headline": "Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick",
    "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
    "url": "https://finnhub.io/api/news?id=73d5ea9805098ac5e5bd98e3dee89350f274b4d5984934fa6233be866779bc1c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754574303,
      "headline": "Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick",
      "id": 136267147,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MCK",
      "source": "Yahoo",
      "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
      "url": "https://finnhub.io/api/news?id=73d5ea9805098ac5e5bd98e3dee89350f274b4d5984934fa6233be866779bc1c"
    }
  },
  {
    "ts": null,
    "headline": "MCK Stock Down Despite Q1 Earnings Beat & Raised '26 EPS View",
    "summary": "McKesson beats on Q1 earnings and raises FY26 EPS view, but shares slip as gross margin narrows and spin-off plans weigh on investors' sentiment.",
    "url": "https://finnhub.io/api/news?id=a4f67ee382b998426a2b25b5a92c85ab33080f0781a16576caa21cb763c07d21",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754569320,
      "headline": "MCK Stock Down Despite Q1 Earnings Beat & Raised '26 EPS View",
      "id": 136266896,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MCK",
      "source": "Yahoo",
      "summary": "McKesson beats on Q1 earnings and raises FY26 EPS view, but shares slip as gross margin narrows and spin-off plans weigh on investors' sentiment.",
      "url": "https://finnhub.io/api/news?id=a4f67ee382b998426a2b25b5a92c85ab33080f0781a16576caa21cb763c07d21"
    }
  }
]